Clinical Trials
3 results.
November 1, 2022
Combining two cancer medications may increase survival in relapsed myelodysplastic syndrome, lays groundwork for future cancer therapies
GRAND RAPIDS, Mich. (Nov. 1, 2022) — A pair of cancer medications that act as a one-two punch against malignant cells demonstrated increased survival in…
May 15, 2017
VARI cancer researcher elected to National Academy of Sciences
GRAND RAPIDS, Mich. (May 15, 2017) — Stephen Baylin, M.D., Director’s Scholar and professor in the Center of Epigenetics at
March 7, 2017
New drug combination targets aggressive blood cancer
Safety and efficacy of combining talazoparib with decitabine to treat acute myeloid leukemia (AML) are subject of multi-site clinical trial
GRAND RAPIDS, Mich. (March 7,…